FDA Warning Letter — GLP-1 Solution

Case 715883 — FEI 3039699528

The FDA took a Warning Letter action against GLP-1 Solution on Sep 9, 2025 (Berlin, Germany). The action was issued by CDER and concerns drugs products.

Action details

Facility
GLP-1 Solution
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Berlin (Germany)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.